The store will not work correctly when cookies are disabled.
(R)-gamma-(4-trifuoromethylbenzyl)-L-proline Hydrochloride
ID: ALA4080252
Cas Number: 1049743-68-1
PubChem CID: 2762030
Max Phase: Preclinical
Molecular Formula: C13H15ClF3NO2
Molecular Weight: 273.25
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cl.O=C(O)[C@@H]1C[C@@H](Cc2ccc(C(F)(F)F)cc2)CN1
Standard InChI: InChI=1S/C13H14F3NO2.ClH/c14-13(15,16)10-3-1-8(2-4-10)5-9-6-11(12(18)19)17-7-9;/h1-4,9,11,17H,5-7H2,(H,18,19);1H/t9-,11+;/m1./s1
Standard InChI Key: LZNHALZTDTVONZ-XQKZEKTMSA-N
Molfile:
RDKit 2D
20 20 0 0 0 0 0 0 0 0999 V2000
26.9203 -6.9927 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
28.1449 -7.0206 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.9699 -7.0206 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.2267 -6.2365 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5574 -5.7498 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.8924 -6.2365 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5561 -4.9249 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.2699 -4.5113 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9818 -4.9242 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.6952 -4.5113 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.6943 -3.6854 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9743 -3.2742 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.2640 -3.6894 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.4540 -7.6886 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.1176 -8.4418 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
30.2746 -7.6033 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.4077 -3.2709 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.1233 -3.6813 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
31.4054 -2.4459 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
32.1198 -2.8541 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
6 2 1 0
5 7 1 6
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 8 1 0
3 14 1 1
14 15 1 0
14 16 2 0
11 17 1 0
17 18 1 0
17 19 1 0
17 20 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 273.25 | Molecular Weight (Monoisotopic): 273.0977 | AlogP: 2.31 | #Rotatable Bonds: 3 |
Polar Surface Area: 49.33 | Molecular Species: ZWITTERION | HBA: 2 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 1.71 | CX Basic pKa: 11.48 | CX LogP: 0.25 | CX LogD: 0.25 |
Aromatic Rings: 1 | Heavy Atoms: 19 | QED Weighted: 0.89 | Np Likeness Score: 0.07 |
References
1. (2014) D-serine transporter inhibitors as pharmaceutical compositions for the treatment of central nervous system disorders, |
2. Singh K, Tanui R, Gameiro A, Eisenberg G, Colas C, Schlessinger A, Grewer C.. (2017) Structure activity relationships of benzylproline-derived inhibitors of the glutamine transporter ASCT2., 27 (3): [PMID:28057420] [10.1016/j.bmcl.2016.12.063] |